Asset Details
Do you wish to reserve the book?
A performance evaluation of sthemO 301 coagulation analyzer and associated reagents
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A performance evaluation of sthemO 301 coagulation analyzer and associated reagents
Do you wish to request the book?
A performance evaluation of sthemO 301 coagulation analyzer and associated reagents
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A performance evaluation of sthemO 301 coagulation analyzer and associated reagents
2023
Overview
Aim The study objective was to evaluate the performance of sthemO 301 system and to compare it with the analyzer used in our university hospital laboratory (STA R Max® 2), for a selection of hemostasis parameters. Methods Method comparison (according to CLSI EP09‐A3), carryover (according to CLSI H57‐A), APTT sensitivity to heparin (according to CLSI H47‐A2), HIL level assessment, and productivity were performed using leftover samples from our laboratory (n > 1000). Commercial quality control materials were used to evaluate precision (according to CLSI EP15‐A3) and accuracy. The assays tested on sthemO 301 were: PT, APTT (silica and kaolin activators), fibrinogen (Fib), thrombin time (TT), chromogenic and clotting protein C (PC) activity, and von Willebrand factor antigen (VWF:Ag) levels. Results All intra‐assay and inter‐assay precision CVs were below the maximal precision limit proposed by the French Group for Hemostasis and Thrombosis (GFHT). Accuracy was verified with bias below GFHT criteria and most Z‐scores were between −2 and +2. No clinically relevant carryover was detected. Silica APTT reagent sensitivity to unfractionated heparin was moderate, as expected. Productivity results were consistent over the 10 repeats performed. The overall agreement between the two systems was excellent for all assays, with Spearman rank correlation coefficient all above 0.9 and slopes of Passing–Bablok correlation near 1 and intercepts close to 0. Conclusion For the methods tested, sthemO 301 system met all the criteria to implement a novel coagulation analyzer in the laboratory and result comparability with STA R Max® 2 was good. Comparison of the performances of sthemO 301 and STA R Max® systems in an university hemostasis laboratory for a selection of hemostasis parameters.
